Hiroki Yamaue Selected Research

Squamous Cell Carcinoma (Epidermoid Carcinoma)

1/2019	Triplet chemotherapy with docetaxel, cisplatin and S-1 for unresectable advanced squamous cell carcinoma of the esophagus: phase I/II trial results.
1/2018	Phase I/II Trial of Chemotherapy with Docetaxel, Cisplatin, and S-1 for Unresectable Advanced Squamous Cell Carcinoma of the Esophagus.
1/2017	Expression of BRCA1, a factor closely associated with relapse-free survival, in patients who underwent neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil for squamous cell carcinoma of the esophagus.
2/2016	Neoadjuvant Chemotherapy with Divided-dose Docetaxel, Cisplatin and Fluorouracil for Patients with Squamous Cell Carcinoma of the Esophagus.
3/2008	An analysis of the factors contributing to a reduction in the incidence of pulmonary complications following an esophagectomy for esophageal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroki Yamaue Research Topics

Disease

160	Neoplasms (Cancer) 01/2024 - 01/2002
64	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 11/2002
46	Stomach Neoplasms (Stomach Cancer) 05/2023 - 03/2002
38	Neoplasm Metastasis (Metastasis) 10/2023 - 06/2002
35	Pancreatic Fistula (Pancreatic Fistulas) 01/2023 - 01/2005
27	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 03/2005
27	Adenocarcinoma 12/2023 - 05/2008
23	Colorectal Neoplasms (Colorectal Cancer) 08/2022 - 03/2002
18	Esophageal Neoplasms (Esophageal Cancer) 01/2024 - 03/2008
18	Infections 05/2018 - 10/2003
17	Hemorrhage 10/2023 - 07/2006
13	Carcinoma (Carcinomatosis) 10/2023 - 07/2004
13	Lymphatic Metastasis 01/2022 - 03/2006
9	Rectal Neoplasms (Rectal Cancer) 05/2023 - 09/2007
8	Anastomotic Leak 01/2022 - 12/2011
7	Esophageal Squamous Cell Carcinoma 09/2023 - 09/2003
7	Colonic Neoplasms (Colon Cancer) 07/2023 - 03/2003
5	Liver Neoplasms (Liver Cancer) 10/2022 - 05/2012
5	Diabetes Mellitus 01/2022 - 01/2009
5	Fistula 09/2020 - 11/2006
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 03/2008
5	Carcinogenesis 01/2016 - 03/2010
4	COVID-19 01/2023 - 01/2020
4	Neoplasms, Cystic, Mucinous, and Serous 01/2023 - 09/2009
4	Margins of Excision 01/2022 - 12/2015
4	Body Weight (Weight, Body) 05/2021 - 09/2009
4	Ascites 01/2020 - 09/2004
4	Anemia 01/2020 - 11/2006
4	Fatigue 01/2020 - 01/2017
4	Pathologic Constriction (Stenosis) 01/2019 - 11/2007
4	Peptic Esophagitis (Reflux Esophagitis) 01/2019 - 07/2014
4	Pain (Aches) 07/2018 - 01/2007
4	Surgical Wound Infection 12/2017 - 07/2007
4	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 09/2016 - 03/2002
4	Melanoma (Melanoma, Malignant) 02/2016 - 03/2002
3	Disease Progression 01/2024 - 01/2011
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 02/2016
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2023 - 06/2013
3	Atrial Fibrillation 12/2022 - 05/2014
3	Inflammation (Inflammations) 10/2022 - 03/2006
3	Acute Cholecystitis 03/2022 - 03/2004

Drug/Important Bio-Agent (IBA)

23	AntigensIBA 01/2024 - 08/2002
18	Gemcitabine FDA Link 01/2024 - 02/2010
15	Fluorouracil (Carac)FDA LinkGeneric 10/2023 - 05/2003
14	Peptides (Polypeptides)IBA 01/2020 - 07/2004
13	Proteins (Proteins, Gene)FDA Link 11/2022 - 10/2007
12	Anti-Infective Agents (Microbicides)IBA 12/2014 - 10/2003
11	CarbohydratesIBA 01/2024 - 05/2011
11	Cisplatin (Platino)FDA LinkGeneric 10/2023 - 09/2003
11	Protein Subunit VaccinesIBA 01/2020 - 02/2010
10	Carcinoembryonic AntigenIBA 01/2021 - 09/2002
10	Messenger RNA (mRNA)IBA 01/2017 - 03/2002
9	130-nm albumin-bound paclitaxelIBA 01/2024 - 01/2017
9	Tumor Biomarkers (Tumor Markers)IBA 01/2023 - 01/2002
8	VaccinesIBA 11/2022 - 02/2008
8	EpitopesIBA 07/2018 - 12/2010
8	Cancer VaccinesIBA 01/2018 - 01/2005
7	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2017
7	RNA (Ribonucleic Acid)IBA 10/2022 - 10/2007
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2002
7	Complementary DNA (cDNA)IBA 01/2022 - 09/2002
7	CEACAM1 ProteinIBA 01/2019 - 08/2011
6	Docetaxel (Taxotere)FDA Link 09/2023 - 02/2016
6	CytokinesIBA 02/2021 - 05/2005
6	Protein Isoforms (Isoforms)IBA 01/2019 - 08/2011
5	Prothrombin (Factor II)IBA 08/2023 - 12/2011
5	AntibodiesIBA 01/2023 - 01/2002
4	Circulating Tumor DNAIBA 01/2024 - 10/2019
4	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2023 - 01/2012
4	ChromatinIBA 03/2020 - 02/2011
4	Small Interfering RNA (siRNA)IBA 01/2013 - 03/2010
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2008 - 08/2002
3	ProdrugsIBA 01/2023 - 03/2003
3	Hemoglobins (Hemoglobin)IBA 07/2021 - 01/2020

Therapy/Procedure

54	Therapeutics 11/2023 - 01/2002
45	Pancreatectomy 12/2023 - 11/2002
44	Pancreaticoduodenectomy 05/2023 - 07/2002
42	Drug Therapy (Chemotherapy) 01/2024 - 01/2001
36	Gastrectomy 05/2023 - 05/2004
27	Hepatectomy 02/2023 - 09/2003
19	Esophagectomy 01/2024 - 03/2008
19	Neoadjuvant Therapy 11/2023 - 02/2014
18	Adjuvant Chemotherapy 01/2023 - 11/2002
18	Lymph Node Excision (Lymph Node Dissection) 09/2022 - 09/2005
13	Immunotherapy 05/2021 - 10/2007
10	Operative Time 08/2022 - 07/2006
9	Radiotherapy 11/2023 - 01/2001
9	Stents 11/2021 - 09/2003
8	Operative Surgical Procedures 12/2023 - 03/2006
8	Length of Stay 08/2019 - 01/2009
7	Splenectomy 02/2023 - 01/2008
7	Pancreaticojejunostomy 07/2020 - 07/2005
5	Liver Transplantation 08/2023 - 06/2016
5	Laparoscopic Cholecystectomy 03/2022 - 10/2003
5	Sutures (Suture) 01/2019 - 01/2008
4	Colectomy 07/2023 - 02/2013
4	Oncolytic Virotherapy 11/2021 - 05/2013
4	Fundoplication 05/2021 - 07/2014
4	Chemoradiotherapy 06/2019 - 03/2012
3	Laparotomy 04/2022 - 09/2014